Related Experiment Videos
Primary sarcomas of the heart
A P Burke1, D Cowan, R Virmani
1Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, D.C. 20306-6000.
Cancer
|January 15, 1992
Summary
Primary cardiac sarcomas have a poor prognosis, with survival linked to tumor location and mitotic activity. Early diagnosis and treatment, including chemotherapy and radiation, improve outcomes for these rare heart tumors.
Area of Science:
- Cardiology
- Oncology
- Pathology
Background:
- Primary sarcomas of the heart are rare and aggressive malignancies.
- Histologic classification is crucial for understanding cardiac sarcoma subtypes.
Purpose of the Study:
- To classify primary cardiac sarcomas by histologic type and analyze survival rates.
- To identify prognostic factors influencing patient outcomes in cardiac sarcoma.
Main Methods:
- Retrospective analysis of 75 primary cardiac sarcoma cases.
- Histologic classification, surgical treatment review, and survival correlation with clinical and histologic parameters.
- Univariate and multivariate analyses to determine significant prognostic factors.
Main Results:
- Angiosarcoma and undifferentiated sarcoma were the most common types.
- Overall survival was poor (mean 11 months, median 6 months).
- Favorable prognostic factors included left-sided location, absence of necrosis/metastasis, low mitotic count, and any form of therapy.
Conclusions:
- Histologic grading and low mitotic activity are significant predictors of survival in cardiac sarcomas.
- Therapy, including chemotherapy and radiation, positively impacts survival rates.
- Immunostaining aids diagnosis but not subclassification of cardiac sarcomas.